Just taking a hard pass on all pharmaceuticals developed in the last 20 years is not a highly optimized strategy.
The appropriate way to make medical decisions is based on data, but if a drug is still under patent then the data isn't there.
Referring to IQ as a stand-in for intelligence is yet another blind alley.